Earnings History Data for Orgenesis Inc. (ORGS) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.

Orgenesis Inc.

Orgenesis, Inc. is a biopharmaceutical company. It focused on developing its trans-differentiation technologies for diabetes. The company deals with the combination of cell-based therapy and regenerative medicine into clinical development. Its operating segment consists of Contract Development and Manufacturing Organization and Cellular Therapy Business. Contract Development and Manufacturing Organization segment activity includes MaSTherCell, which specializes in cell therapy development for advanced medicinal products. Cellular Therapy Business segment activity is based on its technology which demonstrates the capacity to induce a shift in the developmental fate of cells from the liver and differentiating them into pancreatic beta cell like insulin producing cells for patients with Type 1 Diabetes. Orgenesis, Inc. is headquartered in Germantown, MD.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
30-03-2022 PM 0:00 AM ET
(Mar 30)		 ORGS Orgenesis Inc. 77.77 -0.20 0.00 0.00 Orgenesis GAAP EPS of -$0.74, revenue of $35.5M
[3/30/2022 7:22 AM]		 3.40 0.05 
(1.49%)		 3.29 -0.06 
(-1.79%)		 2.12 - 6.47 205,963 20,000 23,263
05-08-2021 PM 0:00 AM ET
(Aug 5)		 ORGS Orgenesis Inc. 112.68 0.11 0.00 1.26 Orgenesis EPS beats by $0.12, beats on revenue
[8/5/2021 8:07 AM]		 5.28 0.18 
(3.53%)		 5.32 0.22 
(4.31%)		 4.14 - 8.30 151,032 50,000 10,047
07-05-2021 PM 0:00 AM ET
(May 7)		 ORGS Orgenesis Inc. 100.53 -0.01 0.00 -0.39 Orgenesis reports Q1 results
[5/7/2021 7:11 AM]		 4.91 -0.75 
(-13.25%)		 5.52 -0.14 
(-2.47%)		 4.30 - 8.30 773,129 1,910,000 23,632